Links
Regulation and quality: home health edition. NICE + CADTH = consultants? The start of price transparency? Gottlieb: Use of RWD, machine learning in clinical trials Experiencing patient experience.
Category: Current Events
ICER and Unsupported Price Increases
The Institute for Clinical and Economic Review (ICER) recently announced that it would annually review treatments with significant price increases to determine if these changes are unsupported by evidence on value. I was recently interviewed by Radar on Specialty Pharmacy to discuss the topic. Jason Shafrin, Ph.D., a senior director of policy and economics at…
Friday Links
Women in economics. Opioids and hepatitis C. Fax machines never die. War on drug-related deaths. Expanding tech in clinical trials.
2019 State of the Union Address: A Healthcare Economist Review
As I have done in previous years, below I review and comment on all of the President’s statements related to health care that come from his state of the union address. Many of us have campaigned on the same core promises, to defend American jobs and demand fair trade for American workers, to rebuild and…
Weekend Links
Spouse vs. patient preferences for nursing homes. Food swamps. Medicaid and moral hazard. Medicare access to anti-opioid medications. The price ain’t right. Brexit and access to pharmaceuticals. Cure for cancer?
Friday Links
Government shutdown slows drug approvals. Does emailing your doctor save or cost money? Digital health and direct-to-consumer marketing. A smart watch for epilepsy. Genetic instrumental variables (GIV). The groin crusher.
Why Gavin Newson’s plan to negotiate with drug companies will not lower prices
In one of his first acts as California Governor, Gavin Newson has proposed a way to reduce drug price: let California use its size to negotiate directly with pharmaceutical firms. As the N.Y. Times reports: [O]n Monday, Mr. Newsom signed an executive order proposing a plan that would allow California to directly negotiate with drug manufacturers. The…
Links
Super gonorrhoea The cost of H1N1 influenza outbreaks. Do wellness programs save money? Government shutdown’s impact on healthcare “the marginal return to the tough-on-crime stance may be close to zero”
End of week links
Drug innovation and disease burden. Five lessons not learned from previous government shutdowns. “parents of daughters…become almost twice as risk-averse as parents of sons” Immigration and health care wait time in the US. Drug “kingpin captures cause large…increases to the homicide rate”
2018 Feel Good Health Stories
25 million doses of a new cholera vaccine were administered globally, and preparations began for the largest vaccination drive in history. UNICEF France revealed a sharp fall in daily smokers, with one million fewer lighting up in the past year, and cigarette use among Americans dropped to its lowest level since the Centers for Disease Control and…